Sep 01, 2026
BioAffinity Technologies (BIAF) Stock Jumps 55% on CyPath Lung Cancer Survivor Monitoring News
BioAffinity Technologies (BIAF) stock rallied 55% after revealing CyPath Lung's potential to monitor lung cancer survivors for recurrence. Volume hit 17M shares.
The post BioAffinity Technologies (BIAF) Stock Jumps 55% on CyPath Lung Cancer Survivor Monitoring News appeared first on Blockonomi.
Source: Blockonomi →Related News
- 43 minutes ago
Nasdaq Futures Rise as Tech Optimism and Middle East Oil News Drive Markets
- 44 minutes ago
Nvidia (NVDA) Stock Gains 1.6% as CEO Jensen Huang Pushes Back Against AI Regula...
- 44 minutes ago
Tesla (TSLA) Stock Gains Momentum Following First-Ever Fitch BBB Rating
- 45 minutes ago
Micron (MU) Stock Slides as Taiwan Plant Faces Strike Threat Over Profit-Sharing...
- 1 hour ago
SpaceX (SPCX) Stock: Morgan Stanley Highlights Power Infrastructure as Key AI Di...